Education
About Us
Working with TipRanks
Follow Us
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
PTGX Analyst Ratings
Strong Buy
12 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PTGX Stock 12 Month Forecast
Average Price Target
$72.09
▲(23.04% Upside)
| Highest Price Target$82.00 | Average Price Target$72.09 | Lowest Price Target$65.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
$80
Buy
36.54%
Upside
Reiterated
09/17/25
Leerink Partners
$73
Buy
24.59%
Upside
Initiated
09/15/25
Wedbush
$70
Buy
19.47%
Upside
Reiterated
09/15/25
Citi
$72
Buy
22.89%
Upside
Reiterated
08/08/25
Citizens JMP
$67→$69
Buy
17.77%
Upside
Reiterated
08/07/25
TD Cowen
$65
Buy
10.94%
Upside
Reiterated
08/06/25
BTIG
$82
Buy
39.96%
Upside
Reiterated
07/21/25
Truist Financial
―
Buy
―
Reiterated
07/01/25
J.P. Morgan
$66
Buy
12.65%
Upside
Reiterated
07/01/25
BMO Capital
$72
Buy
22.89%
Upside
Reiterated
06/30/25
Clear Street
$65→$62
Buy
5.82%
Upside
Reiterated
06/03/25
Jefferies
$68
Buy
16.06%
Upside
Reiterated
04/10/25
Goldman Sachs
$43→$38
Hold
-35.14%
Downside
Reiterated
02/24/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$80
Buy
36.54%
Upside
Reiterated
09/17/25
Leerink Partners
$73
Buy
24.59%
Upside
Initiated
09/15/25
Wedbush
$70
Buy
19.47%
Upside
Reiterated
09/15/25
Citi
$72
Buy
22.89%
Upside
Reiterated
08/08/25
Citizens JMP
$67→$69
Buy
17.77%
Upside
Reiterated
08/07/25
TD Cowen
$65
Buy
10.94%
Upside
Reiterated
08/06/25
BTIG
$82
Buy
39.96%
Upside
Reiterated
07/21/25
Truist Financial
―
Buy
―
Reiterated
07/01/25
J.P. Morgan
$66
Buy
12.65%
Upside
Reiterated
07/01/25
BMO Capital
$72
Buy
22.89%
Upside
Reiterated
06/30/25
Clear Street
$65→$62
Buy
5.82%
Upside
Reiterated
06/03/25
Jefferies
$68
Buy
16.06%
Upside
Reiterated
04/10/25
Goldman Sachs
$43→$38
Hold
-35.14%
Downside
Reiterated
02/24/25
Best Analysts Covering Protagonist Therapeutics
1 Month
xxx
Success Rate
15/22 ratings generated profit
Average Return
+10.96%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 68.18% of your transactions generating a profit, with an average return of +10.96% per trade.
3 Months
xxx
Success Rate
10/12 ratings generated profit
Average Return
+17.85%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 83.33% of your transactions generating a profit, with an average return of +17.85% per trade.
1 Year
Success Rate
22/22 ratings generated profit
Average Return
+76.68%
reiterated a buy rating last month
Copying Jonathan Wolleben's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +76.68% per trade.
2 Years
xxx
Success Rate
22/22 ratings generated profit
Average Return
+159.91%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +159.91% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PTGX Analyst Recommendation Trends
Rating
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Strong Buy
14
10
8
5
3
Buy
11
6
11
15
13
Hold
7
8
6
2
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
32
24
25
22
16
Each month's total comprises the sum of three months' worth of ratings.
PTGX Financial Forecast
PTGX Stock Forecast FAQ
What is PTGX’s average 12-month price target, according to analysts?
Based on analyst ratings, Protagonist Therapeutics’s 12-month average price target is 72.09.
What is PTGX’s upside potential, based on the analysts’ average price target?
Protagonist Therapeutics has 23.04% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PTGX a Buy, Sell or Hold?
Protagonist Therapeutics has a consensus rating of Strong Buy which is based on 12 buy ratings, 0 hold ratings and 0 sell ratings.
What is Protagonist Therapeutics’s price target?
The average price target for Protagonist Therapeutics is 72.09. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $82.00 ,the lowest forecast is $65.00. The average price target represents 23.04% Increase from the current price of $58.59.
The highest analyst price target is $82.00 ,the lowest forecast is $65.00. The average price target represents 23.04% Increase from the current price of $58.59.
What do analysts say about Protagonist Therapeutics?
Protagonist Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of PTGX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.